Evidence map›Paper›PMID 30115607›Full record

Observational studyEBioMedicine2018

Non-lab and semi-lab algorithms for screening undiagnosed diabetes: A cross-sectional study.

Wei Li, Bo Xie, Shanhu Qiu, Xin Huang, Juan Chen, Xinling Wang, Hong Li, Qingyun Chen, Qing Wang, Ping Tu and 23 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in EBioMedicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Rapid estimation approach for glycosylated serum protein of human serum based on the combination of deep learning and TD-NMR technology.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Predictive value of protease-activated receptor-2 (PARJournal of cellular and molecular medicine · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 14 institutions in 2 countries.

Wei LiDepartment of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast Uiversity, Nanjing, China.
Bo XieDepartment of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast Uiversity, Nanjing, China.
Shanhu QiuDepartment of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast Uiversity, Nanjing, China.
Xin HuangSchool of Public Health, Southeast University, Nanjing, China.
Juan ChenDepartment of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast Uiversity, Nanjing, China.
Xinling WangDepartment of Endocrinology, People's Hospital of Xinjiang Uyghur Autonomous Region, Urumqi, China.
Hong LiDepartment of Endocrinology, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Qingyun ChenDepartment of Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Qing WangDepartment of Endocrinology, China-Japan Union Hospital of Jilin University, Changchun, China.
Ping TuDepartment of Endocrinology, The Third Hospital of Nanchang, Nanchang, China.
Lihui ZhangDepartment of Endocrinology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Sunjie YanDepartment of Endocrinology, The First Affiliated Hospital of Fujian Medical University, Diabetes Research Institute of Fujian Province, Fuzhou, China.
Kaili LiDepartment of Endocrinology, Xinjiang Uygur Autonomous Region Hospital of traditional Chinese Medicine, Urumqi, China.
Jimilanmu MaimaitimingDepartment of Endocrinology, People's Hospital of Xinjiang Uyghur Autonomous Region, Urumqi, China.
Xin NianDepartment of Endocrinology, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Min LiangDepartment of Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Yan WenDepartment of Endocrinology, China-Japan Union Hospital of Jilin University, Changchun, China.
Jiang LiuDepartment of Endocrinology, The Third Hospital of Nanchang, Nanchang, China.
Mian WangDepartment of Endocrinology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Yongze ZhangDepartment of Endocrinology, The First Affiliated Hospital of Fujian Medical University, Diabetes Research Institute of Fujian Province, Fuzhou, China.
Li MaDepartment of Endocrinology, Xinjiang Uygur Autonomous Region Hospital of traditional Chinese Medicine, Urumqi, China.
Hang WuDepartment of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast Uiversity, Nanjing, China.
Xuyi WangDepartment of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast Uiversity, Nanjing, China.
Xiaohang WangDepartment of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast Uiversity, Nanjing, China.
Jingbao LiuDepartment of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast Uiversity, Nanjing, China.
Min CaiDepartment of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast Uiversity, Nanjing, China.
Zhiyao WangSuzhou MetroHealth Medical Technology, Co., LTD, Suzhou, China.
Lin GuoSuzhou MetroHealth Medical Technology, Co., LTD, Suzhou, China.
Fangqun ChenSuzhou MetroHealth Medical Technology, Co., LTD, Suzhou, China.
Bei WangSchool of Public Health, Southeast University, Nanjing, China.
Sandberg MonicaDepartment of Medical Cell Biology, Uppsala University, SE-75123 Uppsala, Sweden.
Per-Ola CarlssonDepartment of Medical Cell Biology, Uppsala University, SE-75123 Uppsala, Sweden. Electronic address: per-ola.carlsson@mcb.uu.se.
Zilin SunDepartment of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast Uiversity, Nanjing, China. Electronic address: sunzilin1963@126.com.
Zhongda Hospital Southeast University · CNJilin University · CNPeople's Hospital of Xinjiang Uygur Autonomous Region · CNSecond Hospital of Hebei Medical University · CNSoutheast University · CNUppsala University · SEXinjiang Uygur Autonomous Region Uygur Medicine Hospital · CNFirst Affiliated Hospital of Fujian Medical University · CNFirst Affiliated Hospital of GuangXi Medical University · CNFirst Affiliated Hospital of Kunming Medical University · CNFujian Medical University · CNGuangxi Medical University · CNKunming Medical University · CNThird Hospital of Nanchang · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe terrifying undiagnosed rate and high prevalence of diabetes have become a public emergency. A high efficiency and cost-effective early recognition method is urgently needed. We aimed to generate innovative, user-friendly nomograms that can be applied for diabetes screening in different ethnic groups in China using the non-lab or noninvasive semi-lab data.

methodsThis multicenter, multi-ethnic, population-based, cross-sectional study was conducted in eight sites in China by enrolling subjects aged 20-70. Sociodemographic and anthropometric characteristics were collected. Blood and urine samples were obtained 2 h following a standard 75 g glucose solution. In the final analysis, 10,794 participants were included and randomized into model development (n = 8096) and model validation (n = 2698) group with a ratio of 3:1. Nomograms were developed by the stepwise binary logistic regression. The nomograms were validated internally by a bootstrap sampling method in the model development set and externally in the model validation set. The area under the receiver operating characteristic curve (AUC) was used to assess the screening performance of the nomograms. Decision curve analysis was applied to calculate the net benefit of the screening model.

resultsThe overall prevalence of undiagnosed diabetes was 9.8% (1059/10794) according to ADA criteria. The non-lab model revealed that gender, age, body mass index, waist circumference, hypertension, ethnicities, vegetable daily consumption and family history of diabetes were independent risk factors for diabetes. By adding 2 h post meal glycosuria qualitative to the non-lab model, the semi-lab model showed an improved Akaike information criterion (AIC: 4506 to 3580). The AUC of the semi-lab model was statistically larger than the non-lab model (0.868 vs 0.763, P < 0.001). The optimal cutoff probability in semi-lab and non-lab nomograms were 0.088 and 0.098, respectively. The sensitivity and specificity were 76.3% and 81.6%, respectively in semi-lab nomogram, and 72.1% and 67.3% in non-lab nomogram at the optimal cut off point. The decision curve analysis also revealed a bigger decrease of avoidable OGTT test (52 per 100 subjects) in the semi-lab model compared to the non-lab model (36 per 100 subjects) and the existed New Chinese Diabetes Risk Score (NCDRS, 35 per 100 subjects).

conclusionThe non-lab and semi-lab nomograms appear to be reliable tools for diabetes screening, especially in developing countries. However, the semi-lab model outperformed the non-lab model and NCDRS prediction systems and might be worth being adopted as decision support in diabetes screening in China.

Indexed as

AlgorithmsMass ScreeningCross-Sectional StudiesDecision MakingDiabetes MellitusFemaleHumansLogistic ModelsMaleMiddle AgedNomogramsOdds RatioReproducibility of ResultsRisk FactorsDecision curveDiabetesNomogramRisk algorithm

Identifiers

PMID30115607
PMCPMC6154869
OpenAlexW2887407998

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.